Dr Reddy's Laboratories has received approval to manufacture and market generic semaglutide, a weight loss drug, once Novo Nordisk's patent expires in 2026.

The company is banking on key new launches, including weight loss drug Semaglutide and biosimilar Abatacept to drive growth ...

Britain's Medicines and Healthcare products Regulatory Agency seized a large cache of unlicensed weight-loss drugs, including ...

Multibagger penny stock Jayaswal Neco Industries saw increased foreign institutional investor stakes in Q2. The company also ...

Eli Lilly reports new data showing sustained efficacy for Ebglyss with less frequent dosing and strong long-term results for ...

Eli Lilly announced on Friday safety and efficacy results from two separate late-stage studies testing its approved drugs for ...

Many others in the industry also lamented the fact that an important route to generate alpha for investors has been closed by ...

Many others in the industry also lamented the fact that an important route to generate alpha for investors has been closed by ...

Why is the Supreme Court’s directive to notify a new Saranda wildlife sanctuary important for your UPSC exam? What ...

Mumbai, Oct. 24 -- "The introduction of a second brand of Tirzepatide in India through our commercial agreement with Cipla ...

Please provide the article or its content so I can generate an SEO-friendly meta description based on your guidelines.

Eli Lilly (NYSE:LLY) and Incyte (NASDAQ:INCY) are set to seek a label expansion for their JAK inhibitor baricitinib, marketed ...